ReachMD Faculty

Public Profile

Steven Edelman, MD
Steven Edelman, MD
    Program NameLast Air DateHosts/Guests
    Recommendations in the Diagnosis and Treatment of Gestational Diabetes02/20/2018
    • Thomas Moore, MD
    • Steven Edelman, MD
    Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance08/31/2017
    • Steven Edelman, MD
    • Sunder Mudaliar
    How Similar Are Biosimilar Insulins?11/01/2018
    • Steven Edelman, MD
    • Lutz Heinemann, PhD
    Sexual Complications and Diabetes06/08/2016
    • Janis Roszler, CDE, RD, LD/N
    • Steven Edelman, MD
    What Do Young Doctors Know About Diabetes Management?05/26/2016
    • Stephen Ponder, MD, CDE
    • Steven Edelman, MD
    Insulin Pump Practices04/21/2016
    • John Walsh, PA, CDE
    • Steven Edelman, MD
    Inpatient and Outpatient Recommendations for Diabetes04/14/2016
    • Jane Seley, DNP, MPH
    • Steven Edelman, MD
    Psychological Insulin Resistance05/04/2016
    • Linda Siminerio, RN, PhD, CDE
    • Steven Edelman, MD
    Antipsychotics and Metabolic Syndrome02/12/2016
    • David Henderson, MD
    • Steven Edelman, MD
    Potential Non-Invasive Alternatives to Self-Monitoring Devices02/28/2018
    • Jeffrey La Belle, PhD
    • Steven Edelman, MD
    Home Care Management of Diabetes06/20/2016
    • Eric Rackow, MD
    • Steven Edelman, MD
    Overcoming the Challenges of Diabetes: Talking With an 'Amazing Race' Winner01/05/2016
    • Natalie Strand, MD
    • Steven Edelman, MD
    Hypoglycemia on a Clinically Relevant Level03/14/2016
    • Simon Heller, MD
    • Steven Edelman, MD
    Practice vs. Accountability in Diabetes Care03/17/2016
    • Patrick O'Connor, MD
    • Steven Edelman, MD
    Catering Drug Therapies To Specific Subsets of Patients with Type 2 Diabetes01/07/2016
    • Louis Aronne, MD
    • Steven Edelman, MD
    Optimizing Athletic Performance in Type 1 Diabetes12/15/2015
    • Juan Pablo Frías, MD
    • Steven Edelman, MD
    The Key to Successful Adherence to Diabetes Drug Regimens12/16/2015
    • Candis Morello, PharmD, CDE
    • Steven Edelman, MD
    The Potential of Statins to Prevent Diabetic-Related Blindness12/16/2015
    • Steven Edelman, MD
    • Azza El-Remessy, PhD, RPh
    The Impact of Race and Ethnicity on Insulin Regimens09/07/2016
    • Jaime Davidson, MD
    • Steven Edelman, MD
    Using Video Games to Improve Children’s Diets10/15/2015
    • Tom Baranowski, PhD
    • Steven Edelman, MD
    The Treatment of Transplant Patients With Diabetes06/29/2012
    • Linda Raynes Mahony, MS, RD, CDE
    • Steven Edelman, MD
    Meal Time Interventions for Patients with Type 2 Diabetes07/20/2012
    • Matthew Riddle, MD
    • Steven Edelman, MD
    The Value of Behavior Change in Diabetes, for Patients and Professionals06/22/2012
    • Neal Kaufman, MD, MPH
    • Steven Edelman, MD
    New Guidelines for Exercise and Type 2 Diabetes06/15/2012
    • Sheri Colberg-Ochs, PhD
    • Steven Edelman, MD
    Use of Glucagon and Insulin in a Closed-Loop System06/08/2012
    • Edward Damiano, PhD
    • Steven Edelman, MD
    • Steven Russell, MD, PhD
    Changes in Diabetes Care11/14/2017
    • R. Keith Campbell, BPharm, MBA
    • Steven Edelman, MD
    Screening, Diagnosis and Early Treatment for Diabetes and Pregnancy08/31/2016
    • Lois Jovanovic, MD, MACE
    • Steven Edelman, MD
    New Treatment Algorithm for Type 2 Diabetes12/31/2010
    • John Buse, MD, PhD
    • Steven Edelman, MD
    Immune Interventions for Type 1 Diabetes04/20/2012
    • Jay Skyler, MD
    • Steven Edelman, MD
    Choosing Between Insulin and Incretin Therapies12/10/2010
    • Vivian Fonseca, MD, FRCP
    • Steven Edelman, MD
    Pediatric Diabetes Research10/19/2012
    • Alberto Hayek, MD
    • Steven Edelman, MD
    Approaching Patients with Diabetes from a Behavioral Perspective11/26/2010
    • Amy Ozier, PhD, RD
    • Steven Edelman, MD
    Where Do SGLT-2s Fit in the Treatment of Diabetes?11/19/2010
    • Robert Henry, MD
    • Steven Edelman, MD
    Healthcare Reform and Implications for the Treatment of Diabetes11/12/2010
    • Shereen Arent, JD
    • Steven Edelman, MD
    Managing Diabetic Patients with Peripheral Neuropathy11/05/2010
    • Craig Wargon, DPM
    • Steven Edelman, MD
    The Centers for Disease Control’s Approach to Prevention of Diabetes10/29/2010
    • Ann Albright, PhD, RD
    • Steven Edelman, MD
    Diabetes Research: Hope for a Cure in Stem Cells?10/22/2010
    • Emmanuel Baetge, PhD
    • Steven Edelman, MD
    Do We Need to Temper our Enthusiasm for Incretin-Based Therapy?10/08/2010
    • Robert Cuddihy, MD
    • Steven Edelman, MD
    Do Women With Diabetes Have a Greater Risk of Cardiovascular Disease?03/22/2013
    • Jennifer B. Green, MD
    • Steven Edelman, MD
    Glycemic Control and Macrovascular Outcomes in Patients with Diabetes Using the Archimedes Model09/17/2010
    • David Kendall, MD
    • Steven Edelman, MD
    The Role of Incretins for In-Hospital Management10/01/2010
    • Stanley Schwartz, MD
    • Steven Edelman, MD
    The Need to Preserve Beta Cell Function Early09/03/2010
    • Ralph A. DeFronzo, MD
    • Steven Edelman, MD
    Current Guidelines for Inpatient Care of Patients With Diabetes09/10/2010
    • Fred Toffel, MD
    • Steven Edelman, MD
    Closing the Loop: Progress on the Artificial Pancreas Project08/20/2010
    • Aaron Kowalski, PhD
    • Steven Edelman, MD
    Dietary Energy Density, Energy Intake & Managing Obesity and Diabetes08/13/2010
    • Barbara Rolls, PhD
    • Steven Edelman, MD
    What is the Relationship Between Insulin Sensitivity and Puberty?08/06/2010
    • Philip Zeitler, MD, PhD
    • Steven Edelman, MD
    The Increasing Role of the Pharmacist in Diabetes Care07/09/2010
    • Candis Morello, PharmD, CDE
    • Steven Edelman, MD
    Improving the Care and Management of Hispanics with Diabetes06/25/2010
    • Carlos Campos, MD, MPH
    • Steven Edelman, MD
    The Certified Diabetes Educator: A Key Role in the Diabetes Team06/18/2010
    • Angela Norton, RN, CDE, PHN
    • Steven Edelman, MD
    Gastric Surgery for Bypassing Type 2 Diabetes06/11/2010
    • Francesco Rubino, MD
    • Steven Edelman, MD
    Initiating Insulin Therapy for Type 2 Diabetes06/04/2010
    • Anne Louise Peters, MD
    • Steven Edelman, MD
    Addressing the Unique Challenges for Elderly Patients with Diabetes05/28/2010
    • Janice Baker, MBA, RD, CDE, CNSC
    • Steven Edelman, MD
    Integrative Medicine and Managing Diabetes05/21/2010
    • Steven Edelman, MD
    • Erminia (Mimi) Guarneri, MD, FACC, ABOIM
    The Benefits of Moderate Weight Loss in Diabetes05/14/2010
    • Ken Fujioka, MD
    • Steven Edelman, MD
    The Benefits of TZDs for Early Type 2 Diabetes05/07/2010
    • John (Jack) L. Leahy, MD
    • Steven Edelman, MD
    Addressing the Global Diabetes Epidemic04/30/2010
    • Francine Kaufman, MD
    • Steven Edelman, MD
    Advances in Continuous Glucose Monitoring04/23/2010
    • Timothy Bailey, MD
    • Steven Edelman, MD
    Oral Agents for Diabetes: What to Choose and When04/16/2010
    • Andrew Ahmann, MD
    • Steven Edelman, MD
    Skin Care for Patients Living with Diabetes04/02/2010
    • Janet Trowbridge
    • Steven Edelman, MD
    Challenges in Diagnosis and Treatment of Diabetes in Asian Americans04/09/2010
    • Richard Arakaki, MD
    • Steven Edelman, MD
    The SEARCH for Diabetes in Asian and Pacific-Islander Youth03/12/2010
    • Wilfred Fujimoto, MD
    • Steven Edelman, MD
    Multiple Choice: Customizing Insulin Therapy03/05/2010
    • Matthew Riddle, MD
    • Steven Edelman, MD
    Side by Side: Diabetes Patients' Emotional & Behavioral Support03/19/2010
    • William Polonsky, PhD, CDE
    • Steven Edelman, MD
    Effects of Diabetes on the Musculoskeletal System03/26/2010
    • Rachel Kim, MD
    • Steven Edelman, MD
    Clinical Care Implications of ALLHAT02/19/2010
    • Debra Simmons, MD
    • Steven Edelman, MD
    The Potential of Immunotherapy in Type 1 Diabetes02/12/2010
    • Matthias von Herrath, MD
    • Steven Edelman, MD
    Emerging Insulin Pump Technology02/26/2010
    • Nancy Bohannon, MD
    • Steven Edelman, MD
    A Multidisciplinary Approach to Sexual Medicine in Diabetes01/29/2010
    • Steven Edelman, MD
    • Irwin Goldstein, MD
    Novel Pilot Programs in the Prevention of Type 2 Diabetes01/15/2010
    • David Marrero, PhD
    • Steven Edelman, MD
    Apples or Apple Pie: Helping Patients Make Healthy Changes01/22/2010
    • Steven Edelman, MD
    • Joe Piscatella
    Possible Implications of Healthcare Reform on Diabetes Care12/25/2009
    • Kriss Halpern, JD
    • Steven Edelman, MD
    Type 2 Diabetes in Children and Adolescents01/08/2010
    • Stephen Ponder, MD, CDE
    • Steven Edelman, MD
    Interventions Targeting Impaired Glucose Tolerance12/18/2009
    • Robert Henry, MD
    • Steven Edelman, MD
    Are We Close to Development of an Artificial Pancreas?12/04/2009
    • Bruce Buckingham, MD
    • Steven Edelman, MD
    Implications of the ACCORD, ADVANCE and VA Diabetes Trials11/27/2009
    • Richard Bergenstal, MD
    • Steven Edelman, MD
    The International Diabetes Federation's Global Campaign11/13/2009
    • Anne-Marie Felton
    • Steven Edelman, MD
    How Will Pharmacogenomics Play a Role in Diabetes Therapy?01/01/2010
    • Joseph Ma, PharmD
    • Steven Edelman, MD
    DPP-4 Inhibitors: A New Class of Medications12/11/2009
    • Lisa Kroon, PharmD, CD
    • Steven Edelman, MD
    The Importance of Diabetes Education for Patients and Providers11/20/2009
    • Sandra Bourdette
    • Steven Edelman, MD
    New AACE Guidelines for Treating Type 2 Diabetes08/27/2010
    • Daniel Einhorn, MD
    • Steven Edelman, MD
    Diabetic Kidney Disease10/30/2009
    • David Ward, MD
    • Steven Edelman, MD
    NICE-SUGAR: Blood Glucose Levels in the ICU10/23/2009
    • Irl Hirsch, MD, MACP
    • Steven Edelman, MD
    Characteristics of Gestational Diabetes10/09/2009
    • Thomas Moore, MD
    • Steven Edelman, MD
    Weighing Therapeutic Diets for Type 2 Diabetics09/25/2009
    • Steven Edelman, MD
    • Lorena Drago, MS, RD, CDN, CDE
    Sodium-Glucose Transporters: A New Class of Diabetes Medications10/01/2009
    • Steven Edelman, MD
    • Vivian Fonseca, MD, FRCP
    A New Paradigm for the Treatment of Type 2 Diabetes09/18/2009
    • Ralph A. DeFronzo, MD
    • Steven Edelman, MD
    Do Incretins Play An Important Role In the Cardiovascular System?09/11/2009
    • John Buse, MD, PhD
    • Steven Edelman, MD
    The Diabetes Infrastructure: Regulation & Reimbursement09/04/2009
    • Kelly Close, MBA
    • Steven Edelman, MD
    New Developments in Incretins and SGLT Inhibitors08/28/2009
    • Robert Henry, MD
    • Steven Edelman, MD
    A Resurgence of Stents08/21/2009
    • Daniel Blanchard, MD
    • Steven Edelman, MD
    What’s Happening in Hypoglycemia?08/14/2009
    • Patrick J. Boyle, MD
    • Steven Edelman, MD
    New Treatments for Peripheral Diabetic Neuropathy08/07/2009
    • Ingrid Kruse, DPM
    • Steven Edelman, MD
    Do Herbal Remedies and Vitamins Work?07/31/2009
    • Steven Edelman, MD
    • Candis Morello, PharmD, CDE
    Diagnosing and Treating Peripheral Arterial Disease07/24/2009
    • Niren Angle, MD
    • Steven Edelman, MD
    The Challenges of Diagnosing Diabetes in Children07/17/2009
    • Susan Phillips, MD
    • Steven Edelman, MD
    Sexual Dysfunction: Communication is the Key07/10/2009
    • Janis Roszler, CDE, RD, LD/N
    • Steven Edelman, MD
    Common Gastrointestinal Disorders Affecting Diabetics07/03/2009
    • James Wolosin, MD
    • Steven Edelman, MD
    The Link Between Diabetes and Sleep Apnea06/26/2009
    • Shazia Jamil, MD
    • Steven Edelman, MD
    Continuous Glucose Monitoring06/19/2009
    • Chris Sadler, MA, PA-C, CDE
    • Steven Edelman, MD
    Diabetic Retinopathy06/12/2009
    • Steven Edelman, MD
    • Paul Tornambe, MD
    Toward Safe and Effective Insulin Initiation06/05/2009
    • Ian Blumer, MD
    • Steven Edelman, MD
    Register

    We’re glad to see you’re enjoying ReachMD…
    but how about a more personalized experience?

    Register for free